Lotus root, the edible rhizome of Nelumbo nucifera, is a popular traditional herbal medicine in East Asia. It has been known to several beneficial effects, including anti-oxidative effects and anti-inflammatory effects. However, the mechanisms underly...
Lotus root, the edible rhizome of Nelumbo nucifera, is a popular traditional herbal medicine in East Asia. It has been known to several beneficial effects, including anti-oxidative effects and anti-inflammatory effects. However, the mechanisms underlying the anti-inflammatory effects of lotus root are still largely unknown. Furthermore, several recent studies have reported that physiological functions of plant-based foods were further enhanced through fermentation. Thus, the aim of this study is to examine the mechanisms underlying the anti-inflammatory effects of fermented lotus root (FLR) and its major constituent linoleic acid (LA) in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. First, cytotoxicity assay was carried out to investigate whether FLR and LA affect cell viability. When RAW 264.7 cells were treated with FLR or LA, there was no significant cytotoxicity, and cell proliferation increased by LPS was reduced. Nitric oxide (NO) production induced by LPS was decreased due to treatment with FLR in a dose-dependent manner, and treatment with LA significantly decreased NO production at the highest concentration. In addition to that, increased mRNA expression of immune genes including nitric oxide synthase 2 (Nos2), prostaglandin-endoperoxide synthase 2 (Ptgs2), tumor necrosis factor-alpha (Tnf-α), interleukin-1 beta (Il1b), and interleukin-6 (Il6) was reduced when cells were treated with FLR or LA. Phosphorylation of nuclear factor-kappa B (NF-κB) and inhibitor of kappa B alpha (IκBα) was the highest when cells were induced by LPS for 1 h, and treatment with FLR or LA inhibited phosphorylation of NF-κB and IκBα. Besides, nuclear translocation of NF-κB p65 was blocked by treatment with FLR or LA. These results suggest that FLR and LA attenuate pro-inflammatory response through inhibition of NF-κB activation in LPS-induced RAW 264.7 cells.